Search research articles
Contact Us
Filters
Showing results (351-360 of 399) with videos related to
Page
of 40
Sort By:
Journal of the American Society of Nephrology : JASN
|
March 2, 2018
Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease
Eoin P Brennan, Muthukumar Mohan, Aaron McClelland, et al.
Diabetes
|
February 17, 2018
RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to Apoptosis
Shinji Hagiwara, Karly Sourris, Mark Ziemann, et al.
The New England Journal of Medicine
|
June 13, 2020
New-Onset Diabetes in Covid-19
Francesco Rubino, Stephanie A Amiel, Paul Zimmet, et al.
Clinical Kidney Journal
|
September 3, 2021
Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial
Christoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.
Clinical Science (London, England : 1979)
|
February 3, 2016
Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes
Melinda T Coughlan, Tuong-Vi Nguyen, Sally A Penfold, et al.
Diabetes Care
|
March 30, 2004
Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study
Juliana C N Chan, Nelson M S Wat, Wing-Yee So, et al.
Clinical Kidney Journal
|
February 10, 2021
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial
Christoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 20, 2012
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm
Hicham Skali, Julie Lin, Marc A Pfeffer, et al.
Nature Communications
|
March 16, 2018
Compression force sensing regulates integrin α<sub>IIb</sub>β<sub>3</sub> adhesive function on diabetic platelets
Lining Ju, James D McFadyen, Saheb Al-Daher, et al.
Diabetes
|
June 21, 2024
The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA Sequencing
Abdul Waheed Khan, Misbah Aziz, Karly C Sourris, et al.
Page
of 40
Search research articles
Search
Showing results (351-360 of 399) with videos related to
Sort By:
Page
of 40
Journal of the American Society of Nephrology : JASN
|
March 2, 2018
Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease
Eoin P Brennan, Muthukumar Mohan, Aaron McClelland, et al.
Diabetes
|
February 17, 2018
RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to Apoptosis
Shinji Hagiwara, Karly Sourris, Mark Ziemann, et al.
The New England Journal of Medicine
|
June 13, 2020
New-Onset Diabetes in Covid-19
Francesco Rubino, Stephanie A Amiel, Paul Zimmet, et al.
Clinical Kidney Journal
|
September 3, 2021
Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial
Christoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.
Clinical Science (London, England : 1979)
|
February 3, 2016
Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes
Melinda T Coughlan, Tuong-Vi Nguyen, Sally A Penfold, et al.
Diabetes Care
|
March 30, 2004
Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study
Juliana C N Chan, Nelson M S Wat, Wing-Yee So, et al.
Clinical Kidney Journal
|
February 10, 2021
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial
Christoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 20, 2012
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm
Hicham Skali, Julie Lin, Marc A Pfeffer, et al.
Nature Communications
|
March 16, 2018
Compression force sensing regulates integrin α<sub>IIb</sub>β<sub>3</sub> adhesive function on diabetic platelets
Lining Ju, James D McFadyen, Saheb Al-Daher, et al.
Diabetes
|
June 21, 2024
The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA Sequencing
Abdul Waheed Khan, Misbah Aziz, Karly C Sourris, et al.
Page
of 40